Evidence map›Paper›PMID 30626096›Full record

ArticleCancers2019

Mehdi Helali, Matthieu Moreau, Clara Le Fèvre, Céline Heimburger, Caroline Bund, Bernard Goichot, Francis Veillon, Fabrice Hubelé, Anne Charpiot, Georges Noel and 1 more

Abstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mehdi HelaliBiophysics and Nuclear Medicine, University Hospitals of Strasbourg, 67098 Strasbourg, France. mehdi.st.helali@gmail.com.
Matthieu MoreauRadiophysics, Centre Paul-Strauss, UNICANCER, 67065 Strasbourg, France. MMoreau@strasbourg.unicancer.fr.
Clara Le FèvreRadiotherapy, Centre Paul-Strauss, 67065 Strasbourg, France. c-lefevre56@hotmail.fr.
Céline HeimburgerBiophysics and Nuclear Medicine, University Hospitals of Strasbourg, 67098 Strasbourg, France. celine.heimburger@chru-strasbourg.fr.
Caroline BundBiophysics and Nuclear Medicine, University Hospitals of Strasbourg, 67098 Strasbourg, France. caroline.bund@chru-strasbourg.fr.
Bernard GoichotInternal Medicine, University Hospitals of Strasbourg, Strasbourg University, 67098 Strasbourg, France. Bernard.Goichot@chru-strasbourg.fr.
Francis VeillonRadiology, University Hospitals of Strasbourg, Strasbourg University, 67098 Strasbourg, France. Francis.Veillon@chru-strasbourg.fr.
Fabrice HubeléBiophysics and Nuclear Medicine, University Hospitals of Strasbourg, 67098 Strasbourg, France. Fabrice.HUBELE@chru-strasbourg.fr.
Anne CharpiotOtolaryngology and Maxillofacial Surgery, University Hospitals of Strasbourg, 67098 Strasbourg, France. Anne.Charpiot@chru-strasbourg.fr.
Georges NoelRadiotherapy, Centre Paul-Strauss, 67065 Strasbourg, France. gnoel@strasbourg.unicancer.fr.ORCID 0000-0003-4952-5572
Alessio ImperialeBiophysics and Nuclear Medicine, University Hospitals of Strasbourg, 67098 Strasbourg, France. alessio.imperiale@chru-strasbourg.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this simulation study, we assessed differences in gross tumor volume (GTV) in a series of skull base paragangliomas (SBPGLs) using magnetic resonance imaging (MRI),

Indexed as

18F-FDOPAGTVhead and neckparagangliomaPETradiotherapy

Identifiers

PMID30626096
PMCPMC6360018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.